Gene · 9294
Papers2,171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,171
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment. | Nutrients | 2023 | 36615886 | PubTator, text mining | PubMed |
| Molecular profiling of EBV associated diffuse large B-cell lymphoma. | Leukemia | 2023 | 36604606 | PubTator, text mining | PubMed |
| S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma. | J Exp Clin Cancer Res | 2023 | 36600310 | PubTator, text mining | PubMed |
| Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 gene. | Elife | 2023 | 36598122 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate related signalling pathways manipulating virus replication. | Rev Med Virol | 2023 | 36597202 | PubTator, text mining | PubMed |
| Clonal replacement sustains long-lived germinal centers primed by respiratory viruses. | Cell | 2023 | 36565697 | PubTator, text mining | PubMed |
| Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil. | Bioorg Chem | 2023 | 36527992 | PubTator, text mining | PubMed |
| The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination. | Mult Scler Relat Disord | 2023 | 36470168 | PubTator, text mining | PubMed |
| Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence. | J Interferon Cytokine Res | 2023 | 36454249 | PubTator, text mining | PubMed |
| Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis. | Ann Surg Oncol | 2023 | 36396870 | PubTator, text mining | PubMed |
| Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases. | Clin Exp Med | 2023 | 36385416 | PubTator, text mining | PubMed |
| Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance. | Int J Oncol | 2023 | 36382667 | PubTator, text mining | PubMed |
| Chromosome 12 Open Reading Frame 49 Promotes Tumor Growth and Predicts Poor Prognosis in Colorectal Cancer. | Dig Dis Sci | 2023 | 36348128 | PubTator, text mining | PubMed |
| Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis. | Reprod Sci | 2023 | 36289173 | PubTator, text mining | PubMed |
| Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma. | Neural Regen Res | 2023 | 36204852 | PubTator, text mining | PubMed |
| Profiling of bile acids and activated receptor S1PR2 in gingival tissues of periodontitis patients. | J Periodontol | 2023 | 36193723 | PubTator, text mining | PubMed |
| Adverse effect of FTY720P on colonic Na+ /K+ ATPase is mediated via ERK, p38MAPK, PKC, and PI3K. | J Appl Toxicol | 2023 | 35946054 | PubTator, text mining | PubMed |
| Sphingosine 1-phosphate attenuates neuronal dysfunction induced by amyloid-β oligomers through endocytic internalization of NMDA receptors. | FEBS J | 2023 | 35851748 | PubTator, text mining | PubMed |
| Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. | Hepatology | 2023 | 35689610 | PubTator, text mining | PubMed |
| Signal Transduction and Gene Regulation in the Endothelium. | Cold Spring Harb Perspect Med | 2023 | 35667710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9294/papers?page=18